Chris Coulter

1.8k total citations
27 papers, 540 citations indexed

About

Chris Coulter is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Chris Coulter has authored 27 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 17 papers in Infectious Diseases and 6 papers in Surgery. Recurrent topics in Chris Coulter's work include Tuberculosis Research and Epidemiology (17 papers), Mycobacterium research and diagnosis (17 papers) and Infectious Diseases and Mycology (4 papers). Chris Coulter is often cited by papers focused on Tuberculosis Research and Epidemiology (17 papers), Mycobacterium research and diagnosis (17 papers) and Infectious Diseases and Mycology (4 papers). Chris Coulter collaborates with scholars based in Australia, United States and Netherlands. Chris Coulter's co-authors include Rachel Thomson, Robyn Carter, Megan Hargreaves, Flavia Huygens, Evelyn Lavu, Scott C. Bell, Sushil Pandey, Ben J. Marais, Lachlan Coin and Arnold Bainomugisa and has published in prestigious journals such as PLoS ONE, Applied and Environmental Microbiology and CHEST Journal.

In The Last Decade

Chris Coulter

26 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chris Coulter Australia 13 381 269 151 81 75 27 540
Iain Roddick United Kingdom 4 425 1.1× 292 1.1× 239 1.6× 65 0.8× 37 0.5× 7 539
Mohammad Hashemzadeh Iran 15 335 0.9× 283 1.1× 168 1.1× 123 1.5× 91 1.2× 49 611
M. J. Gevaudan France 9 385 1.0× 298 1.1× 160 1.1× 114 1.4× 66 0.9× 19 567
Daniel Greaves United Kingdom 6 425 1.1× 329 1.2× 283 1.9× 94 1.2× 59 0.8× 6 697
Alan Murray New Zealand 11 383 1.0× 377 1.4× 90 0.6× 210 2.6× 130 1.7× 20 646
K T Luh Taiwan 14 251 0.7× 254 0.9× 41 0.3× 75 0.9× 100 1.3× 40 531
Érica Chimara Brazil 20 746 2.0× 539 2.0× 428 2.8× 86 1.1× 128 1.7× 59 887
Ana C. Vallor United States 11 476 1.2× 503 1.9× 83 0.5× 122 1.5× 20 0.3× 13 797
Maureen Cassidy United States 9 367 1.0× 399 1.5× 189 1.3× 22 0.3× 67 0.9× 12 641
P.H. Chandrasekar United States 12 306 0.8× 389 1.4× 68 0.5× 71 0.9× 15 0.2× 23 563

Countries citing papers authored by Chris Coulter

Since Specialization
Citations

This map shows the geographic impact of Chris Coulter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Coulter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Coulter more than expected).

Fields of papers citing papers by Chris Coulter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Coulter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Coulter. The network helps show where Chris Coulter may publish in the future.

Co-authorship network of co-authors of Chris Coulter

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Coulter. A scholar is included among the top collaborators of Chris Coulter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Coulter. Chris Coulter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bainomugisa, Arnold, Evelyn Lavu, Sushil Pandey, et al.. (2022). Evolution and spread of a highly drug resistant strain of Mycobacterium tuberculosis in Papua New Guinea. BMC Infectious Diseases. 22(1). 437–437. 12 indexed citations
3.
Burke, Andrew, Daniel J. Smith, Chris Coulter, et al.. (2021). Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Drug Treatment of Non-Tuberculous Mycobacteria in Cystic Fibrosis. Clinical Pharmacokinetics. 60(9). 1081–1102. 5 indexed citations
4.
Griffith, David E., Rachel Thomson, Patrick A. Flume, et al.. (2021). Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease. CHEST Journal. 160(3). 831–842. 32 indexed citations
5.
Georghiou, Sophia B., Adam Penn‐Nicholson, Margaretha de Vos, et al.. (2021). Analytical performance of the Xpert MTB/XDR® assay for tuberculosis and expanded resistance detection. Diagnostic Microbiology and Infectious Disease. 101(1). 115397–115397. 12 indexed citations
6.
Winthrop, Kevin, Patrick A. Flume, Rachel Thomson, et al.. (2020). Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease: A 12-Month Open-Label Extension Clinical Trial. Annals of the American Thoracic Society. 18(7). 1147–1157. 46 indexed citations
7.
Denholm, Justin T., et al.. (2020). Tuberculosis notifications in Australia, 2015–2018. Communicable Diseases Intelligence. 44. 24 indexed citations
8.
Gibson, Justine, et al.. (2019). The clinical significance of Mycobacterium triplex. Respiratory Medicine. 159. 105808–105808. 1 indexed citations
10.
Bastian, Ivan & Chris Coulter. (2017). Position statement on interferon-γ release assays for the detection of latent tuberculosis infection. Communicable Diseases Intelligence. 41(4). 322–336. 14 indexed citations
11.
Khandaker, Gulam, Frank Beard, Aditi Dey, et al.. (2017). Evaluation of bacille Calmette-Guérin immunisation programs in Australia. Communicable Diseases Intelligence. 41(1). 33–48. 3 indexed citations
12.
Lavu, Evelyn, Chris Coulter, Julia Ershova, et al.. (2016). The Burden of Drug-Resistant Tuberculosis in Papua New Guinea: Results of a Large Population-Based Survey. PLoS ONE. 11(3). e0149806–e0149806. 38 indexed citations
13.
Denholm, Justin T., Chris Coulter, & Ivan Bastian. (2016). Defining a tuberculosis cluster or outbreak. Communicable Diseases Intelligence. 40(3). 356–359. 7 indexed citations
14.
Coulter, Chris. (2016). Infection control guidelines for the management of patients with suspected or confirmed pulmonary tuberculosis in healthcare settings. Communicable Diseases Intelligence. 40(3). 360–366. 5 indexed citations
15.
Thomson, Rachel, et al.. (2013). Factors associated with the isolation of Nontuberculous mycobacteria (NTM) from a large municipal water system in Brisbane, Australia. BMC Microbiology. 13(1). 89–89. 87 indexed citations
16.
Thomson, Rachel, et al.. (2013). Isolation of Nontuberculous Mycobacteria (NTM) from Household Water and Shower Aerosols in Patients with Pulmonary Disease Caused by NTM. Journal of Clinical Microbiology. 51(9). 3006–3011. 7 indexed citations
17.
Coulter, Chris. (2012). Tuberculosis testing.. PubMed. 41(7). 489–92. 3 indexed citations
18.
Tiller, Rebekah, Jay E. Gee, David Lonsway, et al.. (2010). Identification of an unusual Brucella strain (BO2) from a lung biopsy in a 52 year-old patient with chronic destructive pneumonia. BMC Microbiology. 10(1). 23–23. 82 indexed citations
19.
Kidd, Timothy J., et al.. (2008). Burkholderia cepacia complex epidemiology in persons with cystic fibrosis from Australia and New Zealand. Research in Microbiology. 159(3). 194–199. 16 indexed citations
20.
Coulter, Chris & Jenny Robson. (2004). Skin and soft tissue infections due to non-tuberculous mycobacteria. Microbiology Australia. 25(4). 10–14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026